HealthEquity, Inc. Hits New 52-Week High at USD 107.21

HealthEquity, Inc., a small-cap player in the Capital Markets industry, has reached a significant milestone by hitting a new 52-week high of USD 107.21 on August 10, 2026. This achievement underscores the company's strong performance over the past year, with a notable increase of 22.83%, outpacing the S&P 500's performance of 21.34% during the same period. With a market capitalization of USD 6,970 million, HealthEquity demonstrates robust financial metrics, including a price-to-earnings (P/E) ratio of 32.00 and a return on equity of 10.40%. The company's price-to-book ratio stands at 3.31, reflecting its valuation relative to its assets. Despite a lack of dividend yield, HealthEquity's financial health is further indicated by its debt equity figure, which is notably low. As HealthEquity continues to navigate the capital markets landscape, this new high marks a pivotal moment in its ongoing performance trajectory, highlighting its position within the industry.